Skip to main content
Premium Trial:

Request an Annual Quote

ImaGenes Certified for NimbleGen DNA Methylation Services

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche NimbleGen said today that it has certified Berlin-based genomics services company ImaGenes to offer its DNA Methylation Analysis arrays.

ImaGenes passed the certification to become a Certified Service Provider for the DNA Methylation Analysis workflow, which is used in identifying novel genetic markers that can be used in diagnostic and prognostic development programs.

In December 2009, Roche certified ImaGenes to offer NimbleGen microarrays for chromatin immunoprecipitation (ChIP-chip) services.

This certification makes ImaGenes the first NimbleGen service provider in Europe with multiple certifications, Roche said.

"We are convinced that ImaGenes will further drive the penetration of Roche NimbleGen's innovative products in the functional genomics market," Roche NimbleGen VP of Marketing Andreas Görtz said in a statement.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.